BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15477707)

  • 1. Epidemiology of neuroendocrine tumours.
    Taal BG; Visser O
    Neuroendocrinology; 2004; 80 Suppl 1():3-7. PubMed ID: 15477707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.
    Kauffmann RM; Wang L; Phillips S; Idrees K; Merchant NB; Parikh AA
    Ann Surg Oncol; 2014 Oct; 21(11):3422-8. PubMed ID: 25059786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.
    Amarapurkar DN; Juneja MP; Patel ND; Amarapurkar AD; Amarapurkar PD
    Trop Gastroenterol; 2010; 31(2):101-4. PubMed ID: 20862983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut.
    Strosberg J; Gardner N; Kvols L
    Neuroendocrinology; 2009; 89(4):471-6. PubMed ID: 19174605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours.
    Lepage C; Bouvier AM; Faivre J
    Eur J Endocrinol; 2013 Apr; 168(4):R77-83. PubMed ID: 23349330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological implications in the neuroendocrine gastrointestinal system].
    Piette C; Polus M; Louis E
    Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
    Modlin IM; Champaneria MC; Chan AK; Kidd M
    Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
    Kamp K; Damhuis RA; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging syndromes due to neuroendocrine tumors.
    Vinik AI; Gonzales MR
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):19-63, vii. PubMed ID: 21349410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a nationwide survey of gastrointestinal tumors in Japan].
    Ito T; Tanaka M; Imamura M;
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):128-32. PubMed ID: 18536315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of intestinal carcinoids.
    Angeletti S; Annibale B; Marignani M; Corleto VD; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S108-10. PubMed ID: 10604113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry.
    Korse CM; Taal BG; van Velthuysen ML; Visser O
    Eur J Cancer; 2013 May; 49(8):1975-83. PubMed ID: 23352435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.